News | Proton Therapy | January 07, 2016

Global sales were more than double those of 2014; 1,200-1,800 treatment rooms predicted worldwide by 2030

MEDraysintell, proton therapy, global sales 2015

January 7, 2016 — MEDraysintell noticed that in 2015 global proton therapy sales orders grew to record levels at just over $1 billion for a total of 58 proton therapy treatment rooms, more than twice as much as in 2014. Two companies together commanded almost half of these orders.

There is an increasing interest for one-room compact proton therapy centers, which accounted for about 35 percent of the global orders.
 
By the end of 2015, 174 particle therapy treatment rooms were operational worldwide, and projections by 2030 anticipate the proton therapy world market to reach between 1,200 and 1,800 treatment rooms worldwide.
 
There is growing clinical evidence regarding the efficacy of particle therapy that will progressively be used to treat a broader number of indications, according to MEDraysintell. Therefore, there is now a clear positive stance on the future of the proton therapy market, and this technology is becoming a real part of the global radiotherapy world.
 
A complete analysis of the global proton therapy market is provided in the third edition of the World Proton Therapy market report from MEDraysintell. The report, which is a 250-page comprehensive review of the market dynamics on a world basis, analyzes both past and future trends up to the year 2030. The report also contains a detailed profile of 20 promoters, manufacturers or developers of proton and carbon therapy equipment.

For more information: www.medraysintell.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now